Zenocutuzumab, CAS 1969309-56-5

Product Description: Zenocutuzumab (MCLA-128) is a bispecific humanized IgG1 antibody containing two different Fab arms, targeting extracellular domains of HER2 and HER3[1].

Applications: Cancer-Kinase/protease

Formula: N/A

References: [1]Alison M Schram, et al. Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene Rearrangements. Cancer Discov. 2022 May 2;12(5):1233-1247.

CAS Number: 1969309-56-5

Molecular Weight: N/A

Compound Purity: 99.20

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: EGFR

• SKU: MEXHY-P99507-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99507-5
• Package Unit: 5 mg
• Quantity Unit: STK
• Conjugate: Unconjugated